ATE32980T1 - Tabletten mit ph-unabhaengiger kontrollierter freisetzung. - Google Patents

Tabletten mit ph-unabhaengiger kontrollierter freisetzung.

Info

Publication number
ATE32980T1
ATE32980T1 AT84103698T AT84103698T ATE32980T1 AT E32980 T1 ATE32980 T1 AT E32980T1 AT 84103698 T AT84103698 T AT 84103698T AT 84103698 T AT84103698 T AT 84103698T AT E32980 T1 ATE32980 T1 AT E32980T1
Authority
AT
Austria
Prior art keywords
controlled release
dipyridamole
acid
release tablets
independent controlled
Prior art date
Application number
AT84103698T
Other languages
English (en)
Inventor
Jung-Yong Dr Park
Jerzy Debski
Kieran G Dr Mooney
Original Assignee
Boehringer Ingelheim Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Ltd filed Critical Boehringer Ingelheim Ltd
Application granted granted Critical
Publication of ATE32980T1 publication Critical patent/ATE32980T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT84103698T 1983-04-08 1984-04-04 Tabletten mit ph-unabhaengiger kontrollierter freisetzung. ATE32980T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48328583A 1983-04-08 1983-04-08
EP84103698A EP0121901B1 (de) 1983-04-08 1984-04-04 Tabletten mit pH-unabhängiger kontrollierter Freisetzung

Publications (1)

Publication Number Publication Date
ATE32980T1 true ATE32980T1 (de) 1988-04-15

Family

ID=23919470

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84103698T ATE32980T1 (de) 1983-04-08 1984-04-04 Tabletten mit ph-unabhaengiger kontrollierter freisetzung.

Country Status (20)

Country Link
EP (1) EP0121901B1 (de)
JP (1) JPS6034906A (de)
KR (1) KR880002139B1 (de)
AT (1) ATE32980T1 (de)
AU (1) AU570446B2 (de)
CA (1) CA1219216A (de)
DD (1) DD222496A5 (de)
DE (1) DE3469848D1 (de)
DK (1) DK166259C (de)
ES (1) ES8601687A1 (de)
FI (1) FI82604C (de)
GR (1) GR81907B (de)
HU (1) HU191542B (de)
IE (1) IE57220B1 (de)
IL (1) IL71458A (de)
NO (1) NO164958C (de)
NZ (1) NZ207768A (de)
PH (1) PH21585A (de)
PT (1) PT78380B (de)
ZA (1) ZA842562B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5188840A (en) * 1985-09-26 1993-02-23 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
JPH0776172B2 (ja) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 マトリツクス錠
JP2535141B2 (ja) * 1995-01-17 1996-09-18 中外製薬株式会社 フマル酸含有徐放性製剤
DE10337697A1 (de) * 2003-08-16 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tablette enthaltend 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenyl-amino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester oder dessen Salze
BG860Y1 (bg) * 2004-09-17 2007-02-28 "Софарма" Ад Лекарствена форма на дипиридамол
RU2442574C2 (ru) * 2005-08-22 2012-02-20 Новартис Аг ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ pН-ЗАВИСИМОЕ ЛЕКАРСТВЕННОЕ СРЕДСТВО, МОДИФИКАТОР pН И ЗАМЕДЛЯЮЩИЙ АГЕНТ
JP5111517B2 (ja) 2006-12-13 2013-01-09 エフ．ホフマン−ラ ロシュ アーゲー バルガンシクロビルの粉末製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
DE3124090A1 (de) * 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤

Also Published As

Publication number Publication date
FI841369A (fi) 1984-10-09
KR840008588A (ko) 1984-12-17
AU570446B2 (en) 1988-03-17
FI82604C (fi) 1991-04-10
ZA842562B (en) 1985-12-24
IE57220B1 (en) 1992-06-03
FI841369A0 (fi) 1984-04-06
DK181084A (da) 1984-10-09
DK166259B (da) 1993-03-29
PT78380B (en) 1986-08-14
ES531346A0 (es) 1985-11-01
DK166259C (da) 1993-08-23
AU2660984A (en) 1984-10-11
PH21585A (en) 1987-12-11
DK181084D0 (da) 1984-04-06
FI82604B (fi) 1990-12-31
JPS6034906A (ja) 1985-02-22
IL71458A0 (en) 1984-07-31
CA1219216A (en) 1987-03-17
JPH0521892B2 (de) 1993-03-25
NO841372L (no) 1984-10-09
GR81907B (de) 1984-12-12
DE3469848D1 (en) 1988-04-21
EP0121901A1 (de) 1984-10-17
NO164958B (no) 1990-08-27
EP0121901B1 (de) 1988-03-16
ES8601687A1 (es) 1985-11-01
NO164958C (no) 1990-12-05
KR880002139B1 (ko) 1988-10-17
HU191542B (en) 1987-03-30
IE840856L (en) 1984-10-08
HUT34345A (en) 1985-03-28
PT78380A (en) 1984-05-01
NZ207768A (en) 1987-02-20
DD222496A5 (de) 1985-05-22
IL71458A (en) 1987-09-16

Similar Documents

Publication Publication Date Title
MA23170A1 (fr) Procede de preparation d'un nouveau compose .
IL83510A (en) Pharmaceutical compositions containing dipyridamole or mopidamol and o-acetylsalicylic acid or salts thereof and their preparation
DE69212882D1 (de) Gallensäuresalze enthaltende magenstabile pharmazeutische Zusammensetzung zur oralen Verabreichung
ZA894128B (en) Use of gamma-hydroxybutryic acid salts for preparing pharmaceutical compositions for use in the treatment of alcoholism,and the compositions obtained
FI895342A0 (fi) Ibuprofen-brusprodukter.
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
JPS57159772A (en) 3,4-dihydro-5h-2,3-benzodiazepine derivatives, acid addition salts, manufacture and medicinal composition containing them
IL73125A0 (en) 1-benzyl-aminoalkyl-pyrrolidinones and acid addition salts thereof,their preparation and pharmaceutical compositions containing them
GR3001185T3 (en) Stable solid pharmaceutical composition containing ibuprofen and codeine
IL83032A (en) Pharmaceutical compositions containing calcium salts and their preparation
DE3684819D1 (de) Choline-ester-salze enthaltende pharmazeutische zusammensetzung zur erhoehung der absorption der magen-darmwege.
JPS57144219A (en) Azobissalicylic acid and salts thereof and medicinal composition containing them
GB2064514B (en) Flavan compounds and acid addition salts thereof and pharmaceutical compositions thereof
JPS56154417A (en) Use of 3,3'-azobis -(6-hydroxybenzoic acid) as drug and pharmaceutical composition containing it
ATE32980T1 (de) Tabletten mit ph-unabhaengiger kontrollierter freisetzung.
DE3873167D1 (de) Thiazolidin-4-on-derivate und deren saeure-additionssalze.
JPS562977A (en) *33alkylaminoo22hydroxypropoxy**furann22 carboxylic acid anilide and its addition salt* its manufacture and medicinal composition containing it
DK160388D0 (da) Tert-butylamino-3-(phenyl-2'-phenoxy)-1-propanol-2 og syreadditionssalte deraf til anvendelse som terapeutisk aktivt stof
ZA818149B (en) 2-hydroxy-5-(2',4'-difluorophenyl)-benzoic acid derivatives,methods for their preparation,use thereof as pharmacologically active agents and pharmaceutical compositions containing them
IL62445A0 (en) Alkylthio-acylamino acids and salts thereof,their preparation and pharmaceutical compositions containing them
DK453485A (da) 1,2,3,4,6,7,12,1rb-octahydroindolo-(2,3-a)quinolizin-1-yl-alkancarboxylsyreamider og farmaceutisk anvendelige syreadditionssalte deraf,deres fremstilling og anvendelse
BE862305A (fr) 2-bromo-3-chloro-n-2-imidazolidinylidene-benzamine, ses sels d'addition avec des acides, medicaments la renfermant et procedes pour sa preparation

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee